Oxford Immunotec Global PLC 4
4 · Oxford Immunotec Global PLC · Filed Mar 8, 2016
Insider Transaction Report
Form 4
Altieri Richard M.
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2016-03-04+9,795→ 45,380 total - Award
Share Option (Right to Buy)
2016-03-04+40,812→ 40,812 totalExercise: $10.21Exp: 2026-03-04→ Ordinary Shares (40,812 underlying)
Footnotes (2)
- [F1]Option granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2017 through January 1, 2020.